The global immunofluorescence assay analyzers market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for immunofluorescence assay analyzers in various applications such as hospitals and diagnostic centers, pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes. The global immunofluorescence assay analyzers market by type is segmented into enzymelinked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA) and enzyme linked fluorescent immunoassays (ELFA). ELISA accounted for the largest share in the global market in 2018 owing to its high accuracy level. CLIA was also a major contributor due to its low cost of production. ELFA has been witnessing significant growth owing to its high sensitivity levels which are not found in other types of assays. The global immunofluorescence assay analyzers market by application includes hospitals and diagnostic centers, pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes among others. Hospitals & diagnostic centers accounted for the largest share in 2018 due to their large number of patients who need diagnosis on a daily basis which requires more use of these devices than any other application type. Pharmaceuticals & biotechnology companies were also major contributors due to their requirement for accurate diagnosis before launching new drugs or vaccines into markets which require these devices as well as contract research organizations that provide services such as clinical trials management or drug discovery services among others that require these devices too.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases such as cancer, diabetes, and heart disease is driving the growth of the immunofluorescence assay analyzers market.
- The growing demand for immunofluorescence assay analyzers in emerging economies such as China and India is also a major factor driving the growth of this market.
- The increasing number of research and development activities in this field is also a major factor driving the growth of this market.
- Increasing government funding for research and development activities in immunofluorescence assay analyzers is another factor that will drive the growth of this market over the forecast period (2016-2026).
- Increasing awareness about immunofluorescence assay analyzers among healthcare professionals will also drive the growth of this market over the forecast period (2016-2026).
Industry Growth Insights published a new data on “Immunofluorescence Assay Analyzers Market”. The research report is titled “Immunofluorescence Assay Analyzers Market research by Types (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Radioimmunoassay, Enzyme Linked Fluorescent Immunoassay), By Applications (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes, Others), By Players/Companies PerkinElmer, BioMerieux, Inova Diagnostics, Getein Biotech, Lituo Biotechnology, Guangzhou Improve Medical Instruments”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunofluorescence Assay Analyzers Market Research Report
By Type
Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Radioimmunoassay, Enzyme Linked Fluorescent Immunoassay
By Application
Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes, Others
By Companies
PerkinElmer, BioMerieux, Inova Diagnostics, Getein Biotech, Lituo Biotechnology, Guangzhou Improve Medical Instruments
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Immunofluorescence Assay Analyzers Market Report Segments:
The global Immunofluorescence Assay Analyzers market is segmented on the basis of:
Types
Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Radioimmunoassay, Enzyme Linked Fluorescent Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PerkinElmer
- BioMerieux
- Inova Diagnostics
- Getein Biotech
- Lituo Biotechnology
- Guangzhou Improve Medical Instruments
Highlights of The Immunofluorescence Assay Analyzers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Enzyme-Linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Radioimmunoassay
- Enzyme Linked Fluorescent Immunoassay
- By Application:
- Hospitals and Diagnostic Centers
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunofluorescence Assay Analyzers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immunofluorescence assay analyzers are devices that help to analyze the fluorescence of antibodies in a sample. This can be used to determine the amount of specific antibodies present in a sample, and can also be used to identify different types of cells or tissues that have been affected by the presence of specific antibodies.
Some of the major companies in the immunofluorescence assay analyzers market are PerkinElmer, BioMerieux, Inova Diagnostics, Getein Biotech, Lituo Biotechnology, Guangzhou Improve Medical Instruments.
The immunofluorescence assay analyzers market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunofluorescence Assay Analyzers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Immunofluorescence Assay Analyzers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Immunofluorescence Assay Analyzers Market - Supply Chain
4.5. Global Immunofluorescence Assay Analyzers Market Forecast
4.5.1. Immunofluorescence Assay Analyzers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Immunofluorescence Assay Analyzers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Immunofluorescence Assay Analyzers Market Absolute $ Opportunity
5. Global Immunofluorescence Assay Analyzers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Type
5.3.1. Enzyme-Linked Immunosorbent Assay
5.3.2. Chemiluminescence Immunoassay
5.3.3. Radioimmunoassay
5.3.4. Enzyme Linked Fluorescent Immunoassay
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Immunofluorescence Assay Analyzers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Application
6.3.1. Hospitals and Diagnostic Centers
6.3.2. Pharmaceutical and Biotechnology Companies
6.3.3. Contract Research Organizations
6.3.4. Academic and Research Institutes
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Immunofluorescence Assay Analyzers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Immunofluorescence Assay Analyzers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Immunofluorescence Assay Analyzers Demand Share Forecast, 2019-2026
9. North America Immunofluorescence Assay Analyzers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Application
9.4.1. Hospitals and Diagnostic Centers
9.4.2. Pharmaceutical and Biotechnology Companies
9.4.3. Contract Research Organizations
9.4.4. Academic and Research Institutes
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Type
9.7.1. Enzyme-Linked Immunosorbent Assay
9.7.2. Chemiluminescence Immunoassay
9.7.3. Radioimmunoassay
9.7.4. Enzyme Linked Fluorescent Immunoassay
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Immunofluorescence Assay Analyzers Demand Share Forecast, 2019-2026
10. Latin America Immunofluorescence Assay Analyzers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Application
10.4.1. Hospitals and Diagnostic Centers
10.4.2. Pharmaceutical and Biotechnology Companies
10.4.3. Contract Research Organizations
10.4.4. Academic and Research Institutes
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Type
10.7.1. Enzyme-Linked Immunosorbent Assay
10.7.2. Chemiluminescence Immunoassay
10.7.3. Radioimmunoassay
10.7.4. Enzyme Linked Fluorescent Immunoassay
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Immunofluorescence Assay Analyzers Demand Share Forecast, 2019-2026
11. Europe Immunofluorescence Assay Analyzers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Application
11.4.1. Hospitals and Diagnostic Centers
11.4.2. Pharmaceutical and Biotechnology Companies
11.4.3. Contract Research Organizations
11.4.4. Academic and Research Institutes
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Type
11.7.1. Enzyme-Linked Immunosorbent Assay
11.7.2. Chemiluminescence Immunoassay
11.7.3. Radioimmunoassay
11.7.4. Enzyme Linked Fluorescent Immunoassay
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Immunofluorescence Assay Analyzers Demand Share, 2019-2026
12. Asia Pacific Immunofluorescence Assay Analyzers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Application
12.4.1. Hospitals and Diagnostic Centers
12.4.2. Pharmaceutical and Biotechnology Companies
12.4.3. Contract Research Organizations
12.4.4. Academic and Research Institutes
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Type
12.7.1. Enzyme-Linked Immunosorbent Assay
12.7.2. Chemiluminescence Immunoassay
12.7.3. Radioimmunoassay
12.7.4. Enzyme Linked Fluorescent Immunoassay
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Immunofluorescence Assay Analyzers Demand Share, 2019-2026
13. Middle East & Africa Immunofluorescence Assay Analyzers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Application
13.4.1. Hospitals and Diagnostic Centers
13.4.2. Pharmaceutical and Biotechnology Companies
13.4.3. Contract Research Organizations
13.4.4. Academic and Research Institutes
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Immunofluorescence Assay Analyzers Market Size and Volume Forecast by Type
13.7.1. Enzyme-Linked Immunosorbent Assay
13.7.2. Chemiluminescence Immunoassay
13.7.3. Radioimmunoassay
13.7.4. Enzyme Linked Fluorescent Immunoassay
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Immunofluorescence Assay Analyzers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Immunofluorescence Assay Analyzers Market: Market Share Analysis
14.2. Immunofluorescence Assay Analyzers Distributors and Customers
14.3. Immunofluorescence Assay Analyzers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. PerkinElmer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BioMerieux
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Inova Diagnostics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Getein Biotech
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Lituo Biotechnology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Guangzhou Improve Medical Instruments
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook